As of 30 Sep 2025, 47 institutional investors reported holding 5,620,337 shares of PDS Biotechnology Corp - Common (PDSB). This represents 11% of the company’s total 49,594,356 outstanding shares.
The largest institutional shareholders of PDS Biotechnology Corp - Common (PDSB) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 3.8% | 1,901,441 | -2.6% | 0% | $1,920,455 |
| BlackRock, Inc. | 1% | 517,519 | +0.61% | 0% | $522,694 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | 481,999 | +15% | 0% | $486,906 |
| CITADEL ADVISORS LLC | 0.78% | 386,430 | +55% | 0% | $390,294 |
| INSPIRION WEALTH ADVISORS, LLC | 0.69% | 344,394 | +339% | 0.18% | $1,315,585 |
| Squarepoint Ops LLC | 0.59% | 291,627 | +198% | 0% | $294,543 |
| RENAISSANCE TECHNOLOGIES LLC | 0.56% | 275,861 | +161% | 0% | $278,620 |
| BLAIR WILLIAM & CO/IL | 0.5% | 250,000 | 0% | 0% | $252,500 |
| UBS Group AG | 0.4% | 200,236 | -63% | 0% | $202,238 |
| STATE STREET CORP | 0.27% | 133,333 | 0% | 0% | $134,666 |
| NORTHERN TRUST CORP | 0.23% | 113,472 | -7.2% | 0% | $114,607 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 94,344 | +604% | 0% | $95,287 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.18% | 90,497 | -0.19% | 0% | $91,000 |
| Iron Gate Global Advisors LLC | 0.15% | 75,016 | 0.01% | $76,516 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.12% | 61,793 | 0% | $61,000 | |
| Watts Gwilliam & Co., LLC | 0.11% | 55,000 | 0% | 0.01% | $55,550 |
| Tempus Wealth Planning, LLC | 0.1% | 47,800 | 0% | 0.01% | $48,278 |
| JANE STREET GROUP, LLC | 0.07% | 36,581 | -47% | 0% | $36,947 |
| Rockefeller Capital Management L.P. | 0.07% | 34,467 | 0% | $34,812 | |
| Bank of New York Mellon Corp | 0.06% | 29,293 | 0% | 0% | $29,586 |
| XTX Topco Ltd | 0.04% | 19,699 | 0% | $19,896 | |
| Federation des caisses Desjardins du Quebec | 0.04% | 18,800 | 0% | 0% | $18,988 |
| DIMENSIONAL FUND ADVISORS LP | 0.04% | 18,382 | 0% | 0% | $18,566 |
| FIRST MANHATTAN CO. LLC. | 0.03% | 15,000 | 0% | 0% | $15,150 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 14,149 | -37% | 0% | $14,290 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 265,694 | $204,217 | -$129,917 | $0.77 | 4 |
| 2025 Q3 | 5,620,337 | $6,638,921 | -$1,895,965 | $1.01 | 47 |
| 2025 Q2 | 7,451,352 | $9,901,943 | -$1,043,791 | $1.33 | 55 |
| 2025 Q1 | 8,226,452 | $9,789,276 | +$4,484,828 | $1.19 | 46 |
| 2024 Q4 | 4,239,917 | $6,914,602 | -$572,034 | $1.63 | 51 |
| 2024 Q3 | 4,325,988 | $16,519,540 | -$3,544,953 | $3.82 | 56 |
| 2024 Q2 | 5,489,394 | $16,083,121 | -$6,957,012 | $2.93 | 73 |
| 2024 Q1 | 7,611,671 | $30,140,536 | -$4,107,493 | $3.96 | 69 |
| 2023 Q4 | 8,335,087 | $41,487,859 | +$2,355,421 | $4.97 | 74 |
| 2023 Q3 | 7,861,668 | $39,699,832 | -$403,816 | $5.05 | 78 |
| 2023 Q2 | 7,931,948 | $39,898,006 | -$317,214 | $5.03 | 80 |
| 2023 Q1 | 7,611,967 | $46,811,436 | +$1,184,438 | $6.15 | 66 |
| 2022 Q4 | 6,820,799 | $90,031,703 | +$24,029,740 | $13.20 | 63 |
| 2022 Q3 | 5,178,399 | $15,378,000 | -$458,535 | $2.97 | 42 |
| 2022 Q2 | 5,251,472 | $19,171,000 | -$3,835,298 | $3.65 | 46 |
| 2022 Q1 | 5,851,637 | $36,220,000 | -$1,228,374 | $6.19 | 49 |
| 2021 Q4 | 5,916,212 | $47,919,000 | -$12,229,786 | $8.10 | 63 |
| 2021 Q3 | 6,752,518 | $100,597,635 | +$11,330,602 | $14.90 | 58 |
| 2021 Q2 | 5,941,843 | $74,429,183 | +$40,638,979 | $12.55 | 41 |
| 2021 Q1 | 3,145,310 | $14,311,158 | +$1,348,464 | $4.55 | 29 |
| 2020 Q4 | 3,132,654 | $6,703,955 | -$487,455 | $2.14 | 25 |
| 2020 Q3 | 3,298,108 | $7,682,631 | +$3,730,298 | $2.33 | 27 |
| 2020 Q2 | 1,702,221 | $3,419,000 | +$619,479 | $2.01 | 18 |
| 2020 Q1 | 1,628,998 | $1,184,000 | +$761,576 | $0.72 | 19 |
| 2019 Q4 | 539,706 | $1,429,005 | +$70,841 | $2.65 | 15 |
| 2019 Q3 | 509,321 | $1,716,054 | +$122,431 | $3.37 | 16 |
| 2019 Q2 | 460,755 | $2,759,096 | +$1,030,776 | $5.99 | 16 |
| 2019 Q1 | 287,260 | $2,124,000 | +$2,124,000 | $7.39 | 13 |